Cargando…
P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621562/ http://dx.doi.org/10.1097/01.HS9.0000890804.25894.eb |
| _version_ | 1784821586182799360 |
|---|---|
| author | Shi, Zhiyuan Kern, Verena Freihammer, Max Schitz, Jennifer Borchmann, Sven |
| author_facet | Shi, Zhiyuan Kern, Verena Freihammer, Max Schitz, Jennifer Borchmann, Sven |
| author_sort | Shi, Zhiyuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9621562 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96215622022-11-01 P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma Shi, Zhiyuan Kern, Verena Freihammer, Max Schitz, Jennifer Borchmann, Sven Hemasphere Immunotherapy Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621562/ http://dx.doi.org/10.1097/01.HS9.0000890804.25894.eb Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Immunotherapy Shi, Zhiyuan Kern, Verena Freihammer, Max Schitz, Jennifer Borchmann, Sven P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma |
| title | P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma |
| title_full | P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma |
| title_fullStr | P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma |
| title_full_unstemmed | P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma |
| title_short | P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma |
| title_sort | p059: multi-effector cell targeting with half-life extended bispecific scfv in hodgkin lymphoma |
| topic | Immunotherapy |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621562/ http://dx.doi.org/10.1097/01.HS9.0000890804.25894.eb |
| work_keys_str_mv | AT shizhiyuan p059multieffectorcelltargetingwithhalflifeextendedbispecificscfvinhodgkinlymphoma AT kernverena p059multieffectorcelltargetingwithhalflifeextendedbispecificscfvinhodgkinlymphoma AT freihammermax p059multieffectorcelltargetingwithhalflifeextendedbispecificscfvinhodgkinlymphoma AT schitzjennifer p059multieffectorcelltargetingwithhalflifeextendedbispecificscfvinhodgkinlymphoma AT borchmannsven p059multieffectorcelltargetingwithhalflifeextendedbispecificscfvinhodgkinlymphoma |